This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Shikiar R, Heffernan M, Langley RG, Willian MK, Okun MM, Revicki DA.Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: patient-reported outcomes from a phase II randomized controlled trial. Journal of Dermatological Treatment 18: 25-31, No. 1, 2007
Rights and permissions
About this article
Cite this article
Adalimumab significantly improves HRQOL in psoriasis. Pharmacoecon. Outcomes News 524, 13 (2007). https://doi.org/10.2165/00151234-200705240-00034
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705240-00034